Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

Vyome Holdings, Inc PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • Vyome Holdings, Inc pe ratio for the quarter ending 2026-06-30 was -1.38, a change of 16.2 year-over-year.
  • Vyome Holdings, Inc pe ratio for the quarter ending 2026-03-31 was -1.4, a change of 0.35 year-over-year.
  • Vyome Holdings, Inc pe ratio for the quarter ending 2025-12-31 was -1.97.
  • Vyome Holdings, Inc pe ratio for the quarter ending 2025-09-30 was -1.48, a change of 64.5 year-over-year.
  • Vyome Holdings, Inc pe ratio for fiscal 2026 was -1.38.
  • Vyome Holdings, Inc pe ratio for fiscal 2025 was -1.97.
  • Vyome Holdings, Inc pe ratio for fiscal 2024 was -65.99.
  • Vyome Holdings, Inc pe ratio for fiscal 2023 was -51.5, a change of 387.7 from fiscal 2022.
Available history
2016-12-31 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-1.38$15.58M-$11.31M
2026-03-31-1.4$15.27M-$10.93M
2025-12-31-1.97$20.18M-$10.26M
2025-09-30-1.48$13.87M-$9.34M
2025-06-30-17.58$25.61M-$1.46M
2025-03-31-1.75$4.8M-$2.74M
2024-09-30-65.99$398.15M-$6.03M
2024-06-30-3,628.1$32.73B-$9.02M
2024-03-31-2,292.86$25.03B-$10.92M
2023-12-31-51.5$586.43M-$11.39M
2023-09-30-258.77$6.77B-$26.16M
2023-06-30-851.29$29.63B-$34.81M
2023-03-31-968.63$39.48B-$40.76M
2022-12-31-439.2$20.3B-$46.21M
2022-09-30-29,343.38$1.97T-$66.99M
2022-06-30-45,300.99$3.28T-$72.51M
2022-03-31-95,035.8$6.36T-$66.97M
2021-12-31-2,661.77$169.62B-$63.72M
2021-09-30-421,961.5$14.77T-$35.01M
2021-06-30-526,632.96$11.84T-$22.49M
2021-03-31-1,107,868.02$24.59T-$22.19M
2020-12-31-201,486.28$4.55T-$22.58M
2020-09-30-324,527.17$6.15T-$18.96M
2020-06-30-271,615.4$4.75T-$17.48M
2020-03-31-234,566.52$4.84T-$20.65M
2019-12-31-539,277.64$12.77T-$23.68M
2019-09-30-473,735.82$13.04T-$27.52M
2019-06-30-7,081,240.61$216.39T-$30.56M
2019-03-31-9,056,685.56$303.8T-$33.54M
2018-12-31-1,132,829.21$42.35T-$37.38M
2018-09-30-14,114,559.21$546.85T-$38.74M
2018-06-30-8,114,043.54$334.05T-$41.17M
2018-03-31-13,413,647.66$525.09T-$39.15M
2017-12-31-28,948,863.35$1006.41T-$34.77M
2017-09-30-44,814,798.85$1440.35T-$32.14M
2017-06-30-51,377,195.9$1450.38T-$28.23M
2017-03-31-63,333,498.68$1559.97T-$24.63M
2016-12-31-63,099,277.81$1291.45T-$20.47M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-1.38$15.58M-$11.31M
2025-12-31-1.97$20.18M-$10.26M
2024-09-30-65.99$398.15M-$6.03M
2023-12-31-51.5$586.43M-$11.39M
2022-12-31-439.2$20.3B-$46.21M
2021-12-31-2,661.77$169.62B-$63.72M
2020-12-31-201,486.28$4.55T-$22.58M
2019-12-31-539,277.64$12.77T-$23.68M
2018-12-31-1,132,829.21$42.35T-$37.38M
2017-12-31-28,948,863.35$1006.41T-$34.77M
2016-12-31-63,099,277.81$1291.45T-$20.47M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36